DACPLAT
DACPLAT Brand names, DACPLAT Analogs
DACPLAT Brand Names Mixture
- No information avaliable
DACPLAT Chemical_Formula
DACPLAT RX_link
DACPLAT fda sheet
DACPLAT msds (material safety sheet)
DACPLAT Synthesis Reference
DACPLAT Molecular Weight
DACPLAT Melting Point
DACPLAT H2O Solubility
DACPLAT State
DACPLAT LogP
DACPLAT Dosage Forms
DACPLAT Indication
DACPLAT Pharmacology
DACPLAT Absorption
DACPLAT side effects and Toxicity
DACPLAT Patient Information
Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.
Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.
Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.
